COX2 (PTGS2) Human shRNA Plasmid Kit (Locus ID 5743)
CAT#: TG310074
PTGS2 - Human, 4 unique 29mer shRNA constructs in retroviral GFP vector, 5µg of each construct provided
Need custom shRNA service?
Get a free quote
CNY 4,790.00
货期*
现货
规格
Cited in 4 publications. |
Product images
经常一起买 (2)
PTGS2 mouse monoclonal antibody, clone OTI5F12 (formerly 5F12)
CNY 1,999.00
CNY 2,700.00
Specifications
Product Data | |
Product Name | COX2 (PTGS2) Human shRNA Plasmid Kit (Locus ID 5743) |
Locus ID | 5743 |
UniProt ID | P35354 |
Synonyms | COX-2; COX2; GRIPGHS; hCox-2; PGG/HS; PGHS-2; PHS-2 |
Vector | pGFP-V-RS |
Format | Retroviral plasmids |
Kit Components | PTGS2 - Human, 4 unique 29mer shRNA constructs in retroviral GFP vector(Gene ID = 5743). 5µg purified plasmid DNA per construct29-mer scrambled shRNA cassette in pGFP-V-RS Vector, TR30013, included for free. |
RefSeq | NM_000963, NM_000963.1, NM_000963.2, NM_000963.3, BC013734, BC013734.1, BM978796, NM_000963.4 |
Summary | Prostaglandin-endoperoxide synthase (PTGS), also known as cyclooxygenase, is the key enzyme in prostaglandin biosynthesis, and acts both as a dioxygenase and as a peroxidase. There are two isozymes of PTGS: a constitutive PTGS1 and an inducible PTGS2, which differ in their regulation of expression and tissue distribution. This gene encodes the inducible isozyme. It is regulated by specific stimulatory events, suggesting that it is responsible for the prostanoid biosynthesis involved in inflammation and mitogenesis. [provided by RefSeq, Feb 2009] |
shRNA Design | These shRNA constructs were designed against multiple splice variants at this gene locus. To be certain that your variant of interest is targeted, please contact techsupport@origene.com. If you need a special design or shRNA sequence, please utilize our custom shRNA service. |
Performance Guaranteed | OriGene guarantees that the sequences in the shRNA expression cassettes are verified to correspond to the target gene with 100% identity. One of the four constructs at minimum are guaranteed to produce 70% or more gene expression knock-down provided a minimum transfection efficiency of 80% is achieved. Western Blot data is recommended over qPCR to evaluate the silencing effect of the shRNA constructs 72 hrs post transfection. To properly assess knockdown, the gene expression level from the included scramble control vector must be used in comparison with the target-specific shRNA transfected samples. For non-conforming shRNA, requests for replacement product must be made within ninety (90) days from the date of delivery of the shRNA kit. To arrange for a free replacement with newly designed constructs, please contact Technical Services at techsupport@origene.com. Please provide your data indicating the transfection efficiency and measurement of gene expression knockdown compared to the scrambled shRNA control (Western Blot data preferred). |
Citations (4)
The use of this RNAi has been cited in the following citations: |
---|
Identification and validation of COX-2 as a co-target for overcoming cetuximab resistance in colorectal cancer cells
,Lu, Y;Shi, C;Qiu, S;Fan, Z;,
Oncotarget
,PubMed ID 27074568
[PTGS2]
|
IMP1 suppresses breast tumor growth and metastasis through the regulation of its target mRNAs
,Wang, G;Huang, Z;Liu, X;Huang, W;Chen, S;Zhou, Y;Li, D;Singer, RH;Gu, W;,
Oncotarget
,PubMed ID 26910917
[PTGS2]
|
Elucidation of novel 13-series resolvins that increase with atorvastatin and clear infections
,Dalli, J;Chiang, N;Serhan, CN;,
Nat. Med.
,PubMed ID 26236990
[PTGS2]
|
Premetastatic soil and prevention of breast cancer brain metastasis
,Yan Liu, Akemi Kosaka, Maki Ikeura, Gary Kohanbash, Wendy Fellows-Mayle, Linda A. Snyder, and Hideho Okada,
Neuro Oncology, Jul 2013; 15: 891 - 903.
,PubMed ID 23595625
[PTGS2]
|
Documents
Product Manuals |
FAQs |
SDS |
Customer
Reviews
Loading...